Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus (NCT06506214) | Clinical Trial Compass
CompletedNot Applicable
Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus
France202 participantsStarted 2022-10-08
Plain-language summary
This multicenter study aims to evaluate treatment adherence and satisfaction of patients with cutaneous lupus, influenced by perception of the disease, fear of side effects, cost of medications and the doctor-patient relationship. Adherence will be measured by a VAS of 80% or higher on the Medical Adherence Self-Report Inventory scale.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with cutaneous lupus (pure cutaneous or subacute) diagnosed by a dermatologist and under local and/or systemic treatment for cutaneous lupus
* No opposition to participation
* Patient able to complete the questionnaires
* Adult patient
Exclusion Criteria:
* Systemic lupus with multiple visceral involvement
* Cognitive or psychiatric disorders preventing the smooth running of the study
* Pregnant woman
* Patient under guardianship/curatorship or safeguard of justice
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial focused on measuring how well patients stick to their cutaneous lupus treatments — does my current treatment plan have any known adherence challenges I should be aware of, and how might that affect my outcomes?
2Since this was an observational study looking at treatment adherence and satisfaction rather than testing a new drug, could the findings from this research change the way my doctor approaches or monitors my treatment routine?
3The trial has already been completed — is there any published data or results from it that my doctor has seen, and do those results suggest anything relevant to how patients like me tend to manage cutaneous lupus treatments?
4Given that satisfaction with care was also being measured in this study, are there aspects of my current care plan where I might have more input or options that could make it easier for me to stay on track with treatment?
5Since this wasn't a phase trial testing a new therapy, what standard treatments are currently available for cutaneous lupus, and how do doctors typically decide which one is the best fit for a specific patient?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Evaluation of adherence to treatment of patients with cutaneous lupus.